Clinical performance and utilization of 3 PD-L1 immunohistochemical assays

被引：0
|
作者：
Anderson, Steven M.
Horten, Bruce
McCune, Bryan
Paler, Ronald
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-663
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
663
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PD-L1 Expression in Sarcomas: An Immunohistochemical Study
    Cunningham, C.
    Schnabel, J.
    Esebua, M.
    Layfield, L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S48 - S49
  • [22] Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)
    de Ruiter, Emma J.
    Mulder, Frans J.
    Koomen, Bregje M.
    Speel, Ernst-Jan
    van den Hout, Mari F. C. M.
    de Roest, Reinout H.
    Bloemena, Elisabeth
    Devriese, Lot A.
    Willems, Stefan M.
    MODERN PATHOLOGY, 2021, 34 (06) : 1125 - 1132
  • [23] Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)
    Wang, Xinran
    He, Jiankun
    Li, Jinze
    Wu, Chun
    Yue, Meng
    Niu, Shuyao
    Jia, Ying
    Jia, Zhanli
    Cai, Lijing
    Liu, Yueping
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (02)
  • [24] Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)
    Xinran Wang
    Jiankun He
    Jinze Li
    Chun Wu
    Meng Yue
    Shuyao Niu
    Ying Jia
    Zhanli Jia
    Lijing Cai
    Yueping Liu
    Journal of Cancer Research and Clinical Oncology, 150
  • [25] Clinicopathological correlations of PD-L1 expression in thymic epithelial tumours using two immunohistochemical assays
    Masaoutis, C.
    Rontogianni, D.
    Sarantis, P.
    Bobos, M.
    Dana, E.
    Tsoukalas, N.
    Theocharis, S.
    VIRCHOWS ARCHIV, 2020, 477 : S24 - S24
  • [26] Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer
    Mitra, Shreya
    Prince, Emily A.
    Pratt, James
    Novotny, James, Jr.
    Chizhevsky, Vladislav
    Ragheb, Josette William
    Huron, David
    CANCER RESEARCH, 2021, 81 (04)
  • [27] Clinical benefit of neoadjuvant anti-PD-1/PD-L1 utilization among different tumors
    Li, Zhiyang
    Wu, Xin
    Zhao, Yanjie
    Xiao, Yinan
    Zhao, Yunuo
    Zhang, Ting
    Li, Hui
    Sha, Fushen
    Wang, Yating
    Deng, Lei
    Ma, Xuelei
    MEDCOMM, 2021, 2 (01): : 60 - 68
  • [28] Immunohistochemical assessment of the PD-1/PD-L1 axis in follicular lymphoma
    Szumera-Cieckiewicz, A.
    Sokol, K.
    Rymkiewicz, G.
    Jastrzebska, A.
    Paszkiewicz-Kozik, E.
    Kotarska, M.
    Walewski, J.
    Prochorec-Sobieszek, M.
    VIRCHOWS ARCHIV, 2018, 473 : S97 - S98
  • [29] Comparison of PD-L1 assays in head and neck carcinoma
    Jeong, Ji-seon
    Jo, Uiree
    Choi, Gyuheon
    Song, Halim
    Cho, Kyung-ja
    PATHOLOGY, 2024, 56 (07) : 969 - 981
  • [30] Quantitative comparison of PD-L1 immunohistochemical assays in hepatocellular carcinoma: The Blueprint-HCC study.
    Pinato, David James
    Mauri, Francesco A.
    Spina, Paolo
    Cain, Owen
    Siddique, Abdul
    Goldin, Robert D.
    Victor, Stephane
    Pizio, Corinna
    Akarca, Ayse
    Boldorini, Renzo
    Mazzucchelli, Luca
    Black, James M.
    Shetty, Shishir
    Marafioti, Teresa
    Sharma, Rohini
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
12345